These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15166258)

  • 21. Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function.
    Madry C; Mesic I; Bartholomäus I; Nicke A; Betz H; Laube B
    Biochem Biophys Res Commun; 2007 Mar; 354(1):102-8. PubMed ID: 17214961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of extracellular pH on the dynorphin A inhibition of N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
    Oz M; Woods AS; Shippenberg T; Kaminski RM
    Synapse; 2004 May; 52(2):84-8. PubMed ID: 15034914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro characterization of novel NR2B selective NMDA receptor antagonists.
    Kiss L; Cheng G; Bednar B; Bednar RA; Bennett PB; Kane SA; McIntyre CJ; McCauley JA; Koblan KS
    Neurochem Int; 2005 May; 46(6):453-64. PubMed ID: 15769547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor by the anesthetics xenon and isoflurane: evidence from molecular modeling and electrophysiology.
    Dickinson R; Peterson BK; Banks P; Simillis C; Martin JC; Valenzuela CA; Maze M; Franks NP
    Anesthesiology; 2007 Nov; 107(5):756-67. PubMed ID: 18073551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine D(1) and D(3) receptors oppositely regulate NMDA- and cocaine-induced MAPK signaling via NMDA receptor phosphorylation.
    Jiao H; Zhang L; Gao F; Lou D; Zhang J; Xu M
    J Neurochem; 2007 Oct; 103(2):840-8. PubMed ID: 17897358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional in vitro characterization of CR 3394: a novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist.
    Losi G; Lanza M; Makovec F; Artusi R; Caselli G; Puia G
    Neuropharmacology; 2006 Mar; 50(3):277-85. PubMed ID: 16236334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
    Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
    J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the molecular bases for N-methyl-D-aspartate-receptor inhibition versus immobilizing activities of volatile aromatic anesthetics.
    Sewell JC; Raines DE; Eger EI; Laster MJ; Sear JW
    Anesth Analg; 2009 Jan; 108(1):168-75. PubMed ID: 19095845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The inhibitory potency of local anesthetics on NMDA receptor signalling depends on their structural features.
    Gronwald C; Vegh V; Hollmann MW; Hahnenkamp A; Garaj V; Hahnenkamp K
    Eur J Pharmacol; 2012 Jan; 674(1):13-9. PubMed ID: 22079424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors.
    Watanabe C; Orito T; Watanabe H; Mizoguchi H; Yonezawa A; Yanai K; Mobarakeh JI; Onodera K; Sakurada T; Sakurada S
    Eur J Pharmacol; 2008 Feb; 581(1-2):54-63. PubMed ID: 18155693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NMDA receptor subunit-dependent modulation by conantokin-G and Ala7-conantokin-G.
    Ragnarsson L; Yasuda T; Lewis RJ; Dodd PR; Adams DJ
    J Neurochem; 2006 Jan; 96(1):283-91. PubMed ID: 16336218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
    Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
    Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of agmatine on heteromeric N-methyl-D-aspartate receptor channels.
    Askalany AR; Yamakura T; Petrenko AB; Kohno T; Sakimura K; Baba H
    Neurosci Res; 2005 Aug; 52(4):387-92. PubMed ID: 15982768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tweaking agonist efficacy at N-methyl-D-aspartate receptors by site-directed mutagenesis.
    Hansen KB; Clausen RP; Bjerrum EJ; Bechmann C; Greenwood JR; Christensen C; Kristensen JL; Egebjerg J; Bräuner-Osborne H
    Mol Pharmacol; 2005 Dec; 68(6):1510-23. PubMed ID: 16131614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicity of beta-amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-D-aspartate receptor subunits.
    Domingues A; Almeida S; da Cruz e Silva EF; Oliveira CR; Rego AC
    Neurochem Int; 2007 May; 50(6):872-80. PubMed ID: 17403555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain-derived neurotrophic factor acutely enhances tyrosine phosphorylation of the AMPA receptor subunit GluR1 via NMDA receptor-dependent mechanisms.
    Wu K; Len GW; McAuliffe G; Ma C; Tai JP; Xu F; Black IB
    Brain Res Mol Brain Res; 2004 Nov; 130(1-2):178-86. PubMed ID: 15519688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor.
    Masuko T; Nagaoka H; Miyake M; Metori K; Kizawa Y; Kashiwagi K; Igarashi K; Kusama T
    Neurochem Int; 2007 Jan; 50(2):443-9. PubMed ID: 17113196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus.
    Pandis C; Sotiriou E; Kouvaras E; Asprodini E; Papatheodoropoulos C; Angelatou F
    Neuroscience; 2006 Jun; 140(1):163-75. PubMed ID: 16542781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subtype-dependence of N-methyl-D-aspartate receptor modulation by pregnenolone sulfate.
    Horak M; Vlcek K; Chodounska H; Vyklicky L
    Neuroscience; 2006; 137(1):93-102. PubMed ID: 16257494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain.
    Medvedev IO; Malyshkin AA; Belozertseva IV; Sukhotina IA; Sevostianova NY; Aliev K; Zvartau EE; Parsons CG; Danysz W; Bespalov AY
    Neuropharmacology; 2004 Aug; 47(2):175-83. PubMed ID: 15223296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.